The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bone and Mineral Diagnostic Testing Market Research Report 2025
Synopsis
Bone and mineral metabolism disorder is a collective term used to describe various conditions that make bones weak. Bone mineral metabolism maintains sufficient concentration of inorganic ions in blood serum. Progressive chronic kidney disease, especially end-stage renal disease (ESRD), is responsible for adverse changes in bone and mineral metabolism. Increase in serum parathyroid hormone levels due to fall in glomerular filtration rate is an indicator of bone disorder caused by chronic kidney disease. Reduction in kidney function leads to changes in bone mineral homeostasis and in levels of parathyroid hormone (PTH), 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and fibroblast growth factor-23 (FGF-23). Disorders of mineral metabolism in chronic kidney disease (CKD) have been associated with higher mortality than anemia and inadequate dialysis.
The global Bone and Mineral Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bone and Mineral Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone and Mineral Diagnostic Testing.
Report Scope
The Bone and Mineral Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bone and Mineral Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bone and Mineral Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
bioMérieux
Diasorin
Roche Diagnostic
Siemens Healthcare
Quidel
Segment by Type
Instruments
Assays/Consumables
Segment by Application
Vitamin D Testing
Bone Metabolism
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bone and Mineral Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Bone and mineral metabolism disorder is a collective term used to describe various conditions that make bones weak. Bone mineral metabolism maintains sufficient concentration of inorganic ions in blood serum. Progressive chronic kidney disease, especially end-stage renal disease (ESRD), is responsible for adverse changes in bone and mineral metabolism. Increase in serum parathyroid hormone levels due to fall in glomerular filtration rate is an indicator of bone disorder caused by chronic kidney disease. Reduction in kidney function leads to changes in bone mineral homeostasis and in levels of parathyroid hormone (PTH), 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and fibroblast growth factor-23 (FGF-23). Disorders of mineral metabolism in chronic kidney disease (CKD) have been associated with higher mortality than anemia and inadequate dialysis.
The global Bone and Mineral Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bone and Mineral Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone and Mineral Diagnostic Testing.
Report Scope
The Bone and Mineral Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bone and Mineral Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bone and Mineral Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
bioMérieux
Diasorin
Roche Diagnostic
Siemens Healthcare
Quidel
Segment by Type
Instruments
Assays/Consumables
Segment by Application
Vitamin D Testing
Bone Metabolism
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bone and Mineral Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bone and Mineral Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Assays/Consumables
1.3 Market by Application
1.3.1 Global Bone and Mineral Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Vitamin D Testing
1.3.3 Bone Metabolism
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bone and Mineral Diagnostic Testing Market Perspective (2019-2030)
2.2 Bone and Mineral Diagnostic Testing Growth Trends by Region
2.2.1 Global Bone and Mineral Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bone and Mineral Diagnostic Testing Historic Market Size by Region (2019-2024)
2.2.3 Bone and Mineral Diagnostic Testing Forecasted Market Size by Region (2025-2030)
2.3 Bone and Mineral Diagnostic Testing Market Dynamics
2.3.1 Bone and Mineral Diagnostic Testing Industry Trends
2.3.2 Bone and Mineral Diagnostic Testing Market Drivers
2.3.3 Bone and Mineral Diagnostic Testing Market Challenges
2.3.4 Bone and Mineral Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bone and Mineral Diagnostic Testing Players by Revenue
3.1.1 Global Top Bone and Mineral Diagnostic Testing Players by Revenue (2019-2024)
3.1.2 Global Bone and Mineral Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Bone and Mineral Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bone and Mineral Diagnostic Testing Revenue
3.4 Global Bone and Mineral Diagnostic Testing Market Concentration Ratio
3.4.1 Global Bone and Mineral Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bone and Mineral Diagnostic Testing Revenue in 2023
3.5 Bone and Mineral Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Bone and Mineral Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Bone and Mineral Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bone and Mineral Diagnostic Testing Breakdown Data by Type
4.1 Global Bone and Mineral Diagnostic Testing Historic Market Size by Type (2019-2024)
4.2 Global Bone and Mineral Diagnostic Testing Forecasted Market Size by Type (2025-2030)
5 Bone and Mineral Diagnostic Testing Breakdown Data by Application
5.1 Global Bone and Mineral Diagnostic Testing Historic Market Size by Application (2019-2024)
5.2 Global Bone and Mineral Diagnostic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bone and Mineral Diagnostic Testing Market Size (2019-2030)
6.2 North America Bone and Mineral Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bone and Mineral Diagnostic Testing Market Size by Country (2019-2024)
6.4 North America Bone and Mineral Diagnostic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bone and Mineral Diagnostic Testing Market Size (2019-2030)
7.2 Europe Bone and Mineral Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bone and Mineral Diagnostic Testing Market Size by Country (2019-2024)
7.4 Europe Bone and Mineral Diagnostic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bone and Mineral Diagnostic Testing Market Size (2019-2030)
8.2 Asia-Pacific Bone and Mineral Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bone and Mineral Diagnostic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Bone and Mineral Diagnostic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bone and Mineral Diagnostic Testing Market Size (2019-2030)
9.2 Latin America Bone and Mineral Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bone and Mineral Diagnostic Testing Market Size by Country (2019-2024)
9.4 Latin America Bone and Mineral Diagnostic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bone and Mineral Diagnostic Testing Market Size (2019-2030)
10.2 Middle East & Africa Bone and Mineral Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bone and Mineral Diagnostic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Bone and Mineral Diagnostic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Detail
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Bone and Mineral Diagnostic Testing Introduction
11.1.4 Abbott Diagnostics Revenue in Bone and Mineral Diagnostic Testing Business (2019-2024)
11.1.5 Abbott Diagnostics Recent Development
11.2 bioMérieux
11.2.1 bioMérieux Company Detail
11.2.2 bioMérieux Business Overview
11.2.3 bioMérieux Bone and Mineral Diagnostic Testing Introduction
11.2.4 bioMérieux Revenue in Bone and Mineral Diagnostic Testing Business (2019-2024)
11.2.5 bioMérieux Recent Development
11.3 Diasorin
11.3.1 Diasorin Company Detail
11.3.2 Diasorin Business Overview
11.3.3 Diasorin Bone and Mineral Diagnostic Testing Introduction
11.3.4 Diasorin Revenue in Bone and Mineral Diagnostic Testing Business (2019-2024)
11.3.5 Diasorin Recent Development
11.4 Roche Diagnostic
11.4.1 Roche Diagnostic Company Detail
11.4.2 Roche Diagnostic Business Overview
11.4.3 Roche Diagnostic Bone and Mineral Diagnostic Testing Introduction
11.4.4 Roche Diagnostic Revenue in Bone and Mineral Diagnostic Testing Business (2019-2024)
11.4.5 Roche Diagnostic Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Detail
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Bone and Mineral Diagnostic Testing Introduction
11.5.4 Siemens Healthcare Revenue in Bone and Mineral Diagnostic Testing Business (2019-2024)
11.5.5 Siemens Healthcare Recent Development
11.6 Quidel
11.6.1 Quidel Company Detail
11.6.2 Quidel Business Overview
11.6.3 Quidel Bone and Mineral Diagnostic Testing Introduction
11.6.4 Quidel Revenue in Bone and Mineral Diagnostic Testing Business (2019-2024)
11.6.5 Quidel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
